Clearstead Trust’s Guardant Health GH Stock Holding History

Clearstead Trust’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$536	Buy	+3	New	+$490	﹤0.01%	999

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

AGF Management Toronto, Ontario, Canada $24.5B AUM 50.2% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $200B AUM 30.19% 1-Year Est. Return

Clearstead Trust's GH Position: Q3 2026 in Review

Clearstead Trust opened a new position in Guardant Health (GH) in Q3 2026: 3 shares worth $536. The stake represents ﹤0.01% of the portfolio and ranks #999 among its holdings.

350 funds tracked by Wall St. Rank hold GH as of Q3 2026.

Clearstead Trust held 3 shares of Guardant Health worth $536 as of Q3 2026.
Guardant Health was a new Clearstead Trust position in Q3 2026.
Guardant Health made up ﹤0.01% of Clearstead Trust's portfolio in Q3 2026, its #999 holding.
350 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Clearstead Trust's 13F filing for Q3 2026, filed 6 Nov 2026.